Using the drop-down menu below, read about highlighted scientific news for patients from ASCO's Annual Meetings, Symposia, and medical journals for the past three years. You can select a specific year, meeting or publication, and/or a specific topic, such as a type of cancer. Selecting "All" will take you to a complete list of articles that appear under all categories.
This includes ASCO’s Journal of Clinical Oncology and its scientific meetings, including the ASCO Annual Meeting, a five-day meeting held each May/June. To read the Annual Meeting summaries compiled into a yearly newsletter, you can also review Research Round Up: News for Patients from the ASCO Annual Meeting.Don’t forget to check out audio podcasts and videos about this news, as well. And a list of upcoming Symposia can be found here. And, in addition to the highlighted studies below, thousands of scientific abstracts are released each year at different ASCO meetings. To search the entire collection of meeting abstracts, visit ASCO's website.
In two recent studies, researchers found that a newer approach to chemotherapy and a new targeted therapy helps patients with metastatic colorectal cancer live longer.
According to an analysis published in the Journal of Clinical Oncology, patients and survivors who smoked prior to their cancer diagnosis had an up to five times higher risk of developing a second primary cancer than patients who never smoked.
One in three patients with cancer experiences anxiety or other mental health challenges, according to a study published in the Journal of Clinical Oncology. This is the largest and most comprehensive study to date assessing the mental and emotional health of patients with cancer using a standardized, diagnostic face-to-face interview.
New findings from a large group of patients from the national Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial show that men who have a specific form of baldness – at both the front and crown of the head – at the age of 45 have a 40% increased risk of developing aggressive prostate cancer (usually indicates a faster growing tumor resulting in poorer prognosis, relative to “non-aggressive” prostate cancer) later in life, compared to men with no baldness at that age. However, the researchers did not find a link between any type of baldness and risk of non-aggressive prostate cancer.
This is a transcript of a podcast led by Dr. Julia White, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact of sending reminders to women overdue for breast cancer screening with mammography.
This is a transcript of a podcast led by Dr. Harold Burstein, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact that Angelina Jolie’s choice of having surgery to prevent breast cancer had on genetic testing for genes linked to breast cancer risk.
This is a transcript of a podcast led by Dr. Amy Early, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on breast cancer recurrence after chemotherapy given before surgery.
This a transcript of a podcast led by Dr. Julie Margenthaler, who discusses two studies highlighted at the 2014 Breast Cancer Symposium that relate to surgery for breast cancer treatment and prevention.
Women with cervical cancer that has spread to other parts of the body have few treatment options, especially if the disease gets worse during or after treatment. As a result, newer approaches to treatment are needed. A small study looking at a new type of personalized immunotherapy, known as adoptive T-cell therapy, has produced some promising results. This treatment approach boosts the body’s natural defenses against the human papillomavirus (HPV) to fight the cancer.
An early study shows that half of patients with advanced melanoma who received a combination of ipilimumab (Yervoy) and nivolumab, an investigational medication, were alive almost three and a half years later (40 months). That is nearly double the amount of time reported in earlier studies that used either drug by itself.